Alginate based 3D hydrogels as an in vitro co-culture model platform for the toxicity screening of new chemical entities

Toxicology and Applied Pharmacology

Volumn 256, Issue 1, 2011, Pages 62-72

  Lan, Shih Feng ^a   Starly, Binil ^a,b  

^a UNIVERSITY OF OKLAHOMA   (United States)

^b University of Oklahoma   (United States)

Author keywords

3D culture; Alginate; Cell encapsulation; Co culture; HepG2; MCF 7

Indexed keywords

ALGINIC ACID; COUMARIN; POLYCARBONATE; PRODRUG;

ARTICLE; CELL CULTURE; CELL DENSITY; CELL ENCAPSULATION; CELL STRAIN HEPG2; CELL TYPE; COCULTURE; CONTROLLED STUDY; CORRELATIONAL STUDY; DRUG CLEARANCE; DRUG EFFICACY; DRUG SCREENING; DRUG TRANSFORMATION; HUMAN; HUMAN CELL; HYBRID; HYDROGEL; IN VITRO STUDY; LD 50; LIVER CELL; LIVER TOXICITY; THREE DIMENSIONAL COCULTURE MODEL PLATFORM; THREE DIMENSIONAL IMAGING;

ALGINATES; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; DRUG EVALUATION, PRECLINICAL; DRUG TOXICITY; HEP G2 CELLS; HUMANS; HYDROGELS; LIVER; TOXICITY TESTS;

ANIMALIA;

EID: 80052325855     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.07.013     Document Type: Article

References (38)

1. Albano E., Rundgren M., Harvison P.J., Nelson S.D., Moldeus P. Mechanisms of N-acetyl-p-benzoquinone imine cytotoxicity. Mol. Pharmacol. 1985, 28:306-311.
2. Baudoin R., Corlu A., Griscom L., Legallais C., Leclerc E. Trends in the development of microfluidic cell biochips for in vitro hepatotoxicity. Toxicol. In Vitro 2007, 21:535-544.
3. Bender R.P., Lindsey R.H., Burden D.A., Osheroff N. N-acetyl-p-benzoquinone imine, the toxic metabolite of acetaminophen, is a topoisomerase II poison. Biochemistry 2004, 43:3731-3739.
4. Boulares A.H., Ren T. Mechanism of acetaminophen-induced apoptosis in cultured cells: roles of caspase-3, DNA fragmentation factor, and the Ca2+ and Mg2+ endonuclease DNAS1L3. Basic Clin. Pharmacol. Toxicol. 2004, 94:19-29.
5. Burcham P.C., Harman A.W. Acetaminophen toxicity results in site-specific mitochondrial damage in isolated mouse hepatocytes. J. Biol. Chem. 1991, 266:5049-5054.
6. Centola M., Rainer A., Spadaccio C., De P.S., Genovese J.A., Trombetta M. Combining electrospinning and fused deposition modeling for the fabrication of a hybrid vascular graft. Biofabrication 2010, 2:014102.
7. Dahlin D.C., Miwa G.T., Lu A.Y., Nelson S.D. N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. Proc. Natl. Acad. Sci. U. S. A. 1984, 81:1327-1331.
8. David L., Dulong V., Le C.D., Cazin L., Lamacz M., Vannier J.P. Hyaluronan hydrogel: an appropriate three-dimensional model for evaluation of anticancer drug sensitivity. Acta Biomater. 2008, 4:256-263.
9. Dini L., Panzarini E., Miccoli M.A., Miceli V., Protopapa C., Ramires P.A. In vitro study of the interaction of polyalkilimide and polyvinyl alcohol hydrogels with cells. Tissue Cell 2005, 37:479-487.
10. Gache C., Berthois Y., Martin P.M., Saez S. Positive regulation of normal and tumoral mammary epithelial cell proliferation by fibroblasts in coculture. In Vitro Cell Dev. Biol. Anim. 1998, 34:347-351.
11. Gaedtke L., Thoenes L., Culmsee C., Mayer B., Wagner E. Proteomic analysis reveals differences in protein expression in spheroid versus monolayer cultures of low-passage colon carcinoma cells. J. Proteome Res. 2007, 6:4111-4118.
12. Gibb S. Toxicity testing in the 21st century: a vision and a strategy. Reprod. Toxicol. 2008, 25:136-138.
13. Gillette B.M., Jensen J.A., Wang M., Tchao J., Sia S.K. Dynamic hydrogels: switching of 3D microenvironments using two-component naturally derived extracellular matrices. Adv. Mater. 2010, 22:686-691.
14. Gurski L.A., Jha A.K., Zhang C., Jia X., Farach-Carson M.C. Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells. Biomaterials 2009, 30:6076-6085.
15. Hazai E., Vereczkey L., Monostory K. Reduction of toxic metabolite formation of acetaminophen. Biochem. Biophys. Res. Commun. 2002, 291:1089-1094.
16. Horning J.L., Sahoo S.K., Vijayaraghavalu S., Dimitrijevic S., Vasir J.K., Jain T.K., Panda A.K., Labhasetwar V. 3-D tumor model for in vitro evaluation of anticancer drugs. Mol. Pharm. 2008, 5:849-862.
17. Hugo-Wissemann D., Anundi I., Lauchart W., Viebahn R., de G.H. Differences in glycolytic capacity and hypoxia tolerance between hepatoma cells and hepatocytes. Hepatology 1991, 13:297-303.
18. Khetani S.R., Bhatia S.N. Microscale culture of human liver cells for drug development. Nat. Biotechnol. 2008, 26:120-126.
19. Lan S.F., Safiejko-Mroczka B., Starly B. Long-term cultivation of HepG2 liver cells encapsulated in alginate hydrogels: a study of cell viability, morphology and drug metabolism. Toxicol. In Vitro 2010, 24:1314-1323.
20. Lee M.Y., Park C.B., Dordick J.S., Clark D.S. Metabolizing enzyme toxicology assay chip (MetaChip) for high-throughput microscale toxicity analyses. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:983-987.
21. Lee P.J., Hung P.J., Lee L.P. An artificial liver sinusoid with a microfluidic endothelial-like barrier for primary hepatocyte culture. Biotechnol. Bioeng. 2007, 97:1340-1346.
22. Li A.P. Use of Aroclor 1254-induced rat liver homogenate in the assaying of promutagens in Chinese hamster ovary cells. Environ. Mutagen. 1984, 6:539-544.
23. Manov I., Hirsh M., Iancu T.C. N-acetylcysteine does not protect HepG2 cells against acetaminophen-induced apoptosis. Basic Clin. Pharmacol. Toxicol. 2004, 94:213-225.
24. Nahmias Y., Kramvis Y., Barbe L., Casali M., Berthiaume F., Yarmush M.L. A novel formulation of oxygen-carrying matrix enhances liver-specific function of cultured hepatocytes. FASEB J. 2006, 20:2531-2533.
25. Nakamura K., Mizutani R., Sanbe A., Enosawa S., Kasahara M., Nakagawa A., Ejiri Y., Murayama N., Miyamoto Y., Torii T., Kusakawa S., Yamauchi J., Fukuda M., Yamazaki H., Tanoue A. Evaluation of drug toxicity with hepatocytes cultured in a micro-space cell culture system. J. Biosci. Bioeng. 2011, 111:78-84.
26. Paillard F., Finot F., Mouche I., Prenez A., Vericat J.A. Use of primary cultures of rat hepatocytes to predict toxicity in the early development of new chemical entities. Toxicol. In Vitro 1999, 13:693-700.
27. Roe A.L., Snawder J.E., Benson R.W., Roberts D.W., Casciano D.A. HepG2 cells: an in vitro model for P450-dependent metabolism of acetaminophen. Biochem. Biophys. Res. Commun. 1993, 190:15-19.
28. Rotem A., Toner M., Bhatia S., Foy B.D., Tompkins R.G., Yarmush M.L. Oxygen is a factor determining in vitro tissue assembly: effects on attachment and spreading of hepatocytes. Biotechnol. Bioeng. 1994, 43:654-660.
29. Sung J.H., Shuler M.L. A micro cell culture analog (microCCA) with 3-D hydrogel culture of multiple cell lines to assess metabolism-dependent cytotoxicity of anti-cancer drugs. Lab Chip 2009, 9:1385-1394.
30. Toh Y.C., Lim T.C., Tai D., Xiao G., van N.D., Yu H. A microfluidic 3D hepatocyte chip for drug toxicity testing. Lab Chip 2009, 9:2026-2035.
31. Tung Y.C., Hsiao A.Y., Allen S.G., Torisawa Y.S., Ho M., Takayama S. High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array. Analyst 2011, 136:473-478.
32. Uyama N., Shimahara Y., Kawada N., Seki S., Okuyama H., Iimuro Y., Yamaoka Y. Regulation of cultured rat hepatocyte proliferation by stellate cells. J. Hepatol. 2002, 36:590-599.
33. Van V.E. Current standing and future prospects for the technologies proposed to transform toxicity testing in the 21st century. ALTEX 2010, 28:17-44.
34. Varghese D., Deshpande M., Xu T., Kesari P., Ohri S., Boland T. Advances in tissue engineering: cell printing. J. Thorac. Cardiovasc. Surg. 2005, 129:470-472.
35. Viravaidya K., Shuler M.L. Incorporation of 3T3-L1 cells to mimic bioaccumulation in a microscale cell culture analog device for toxicity studies. Biotechnol. Prog. 2004, 20:590-597.
36. Vukasinovic J., Cullen D.K., Laplaca M.C., Glezer A. A microperfused incubator for tissue mimetic 3D cultures. Biomed. Microdevices 2009, 11:1115-1165.
37. Wishart D.S., Knox C., Guo A.C., Cheng D., Shrivastava S., Tzur D., Gautam B., Hassanali M. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008, 36:901-906.
38. Yamada K.M., Cukierman E. Modeling tissue morphogenesis and cancer in 3D. Cell 2007, 130:601-610.